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Abstract
Background: To reach young people for Chlamydia trachomatis (CT) testing, new web-based strategies are used to
offer testing via young people’s sexual and social networks. The success of such peer-driven strategies depends on
whether individuals disclose their own testing and encourage others to get tested. We assessed whether public- and
self-stigma would hamper these behaviours, by comparing anticipations and experiences relating to these issues in
young men and women who already tested or never tested for CT.
Methods: Participants were recruited at an STI clinic and two schools in the Netherlands. Semi-structured interviews
were analysed from 23 sexually active heterosexual young people between 16–24 years using qualitative content
analysis with a framework approach.
Results: Both tested and never tested participants perceived public stigma and anticipated shame and self-stigma in
relation to testing. Maintaining good health was identified as main reason for testing. Never tested and tested
participants anticipated that they would feel shame and receive stigmatizing reactions from people outside their
trusted network if they would disclose their testing, or encourage them to test. From a selected group of trusted
peers, they anticipated social support and empathy. When tested participants disclosed their testing to trusted
peers they did not experience stigma. Due to the fact that no one disclosed their testing behaviour to peers outside
their trusted network, stigma was avoided and therefore tested participants reported no negative reactions.
Similarly, regarding the encouragement of others to test, most tested participants did not experience negative
reactions from sex partners and friends.
Conclusions: Young people perceive public stigma and anticipate self-stigma and shame in relation to CT testing,
disclosure and encouraging others to test. People do test for CT, including those who anticipate stigma. To avoid
stigmatizing reactions, stigma management strategies are applied, such as selective disclosure and the selective
encouragement of others to test (i.e. only in a small trusted peer network). Care strategies that deploy sexual and
social networks of individuals can reach into small networks surrounding a person. These strategies could be improved
by exploring methods to reach high-risk network members outside the small trusted circle of a person.
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Background
Chlamydia trachomatis (CT) is a much underestimated
sexually transmitted infection (STI) and worldwide diag-
noses of CT have increased in recent years [1–4]. CT is
the most diagnosed bacterial STI among sexually active
people, and has potential reproductive sequelae. A major
risk group for CT are young heterosexual people below
25 years of age. They are targeted by health care profes-
sionals using key control strategies that encompass test-
ing, treating, and partner notification (PN), to interrupt
the inherent transmission chain [5, 6]. Several associated
factors, which influence the uptake of these strategies,
have been identified. A systematic review on CT testing
in young women revealed that the uptake of CT testing
was impeded by ignorance and inaccurate information,
denial, moral connotations, stigma, fear, anxiety, confi-
dentiality and privacy concerns, and pragmatic factors
such as cost and test discomfort [7]. Other barriers
among women and men include the embarrassment and
shame associated with seeking care [8, 9], the asymp-
tomatic nature of the infection [6, 10], fear of a positive
test result [6, 11], and perceived STI-related stigma (i.e.,
fear of being subjected to negative societal attitudes and
discrimination) [12]. Facilitators included accurate
knowledge, feelings of personal relevance, multiple test
options (i.e., home-based test kits, self-administered
swabs), free tests, and support with diagnosis [7]. The
process of PN is also influenced by several factors. Bar-
riers to notifying a sex partner, as revealed in a system-
atic review of PN, included stigma, guilt, blame, possible
relationship breakdown, violence, and missing contact
details [13]. Partner notification can be facilitated by
using Patient-Delivered Partner Therapy (i.e., partners
are treated via the patients by providing prescriptions or
medications without a medical personal evaluation), on-
line notification, and home-based test kits [13].
To overcome barriers and explore the facilitators of
CT testing and PN among young people, innovative care
methods have been developed in addition to the regular
care provided by STI clinics and general practitioners in
for instance Europe Australia, and US [13–20]. These
new methods include web-based programmes that utilise
email and text messaging, alongside home-based sam-
pling [18–20]. These programmes aim to facilitate test-
ing in high-risk groups of individuals who are connected
in sexual networks and/or social networks. Peers from
such networks surrounding CT positive individuals are
important targets in CT control, as they typically show
similar high risk, for example with respect to unpro-
tected sex or sex with a CT positive person [21]. Com-
munication in social networks is associated with the
sexual behaviour among friends in these networks [22].
Modelling may also play a role; the actual behaviour of
peers may influence a person’s behaviour, for example
regarding sexual behaviour, but also regarding CT testing
[23]. Therefore, essential components of care methods
that aim to reach high-risk networks include the disclos-
ure of CT testing behaviour to sexual and social network
members and the encouragement to get them tested using
for example the internet and home-based sampling. Suc-
cessful disclosure and encouragement could thus poten-
tially lead to better partner notification and an increase in
CT testing and emotional support among peers [24, 25].
Web-based CT care programs focus on utilising the
factors identified as facilitators for CT testing and PN.
However, factors that have been identified as barriers,
especially stigma [15, 25–28], may still be of concern in
the processes of disclosure and encouragement. A
stigma is a deeply discrediting attribute that results in
widespread social disapproval [29]. It consists of two
fundamental components – the recognition of differ-
ence, and devaluation [30]. Stigmatization has different
manifestations that can be overt (e.g., social rejection,
avoidance) as well as subtle (e.g., lack of eye contact)
[29]. Public stigma refers to the cognitive, affective and
behavioural responses of other people towards an individ-
ual who possesses a stigmatized characteristic. Public
stigma can lead to self-stigma which refers to an individ-
ual’s awareness of his/her stigmatized condition, the social
devaluation connected with his/her condition, and the pos-
sible internalization of this stigma [29]. Public stigma may
shape anticipated stigma in persons with a stigmatized
condition. However, anticipated stigma does not automat-
ically translate into the actual experience of stigma.
Previous studies about stigma surrounding the disclos-
ure of test behaviour have focused on anticipations or
experiences with stigma by young men or women sur-
rounding STI in general [25], HIV [31] and the Human
Papilloma Virus [26]. Previous research on stigma sur-
rounding CT was conducted in a UK population with a
wide age-range [32], limiting the generalizability of the
results to young populations. The present study assessed
both anticipated stigma and experiences with stigma in
young (16–24 years old) heterosexual men and women
who had either never been tested (from here on referred
to as “never tested”) or who had been tested (referred to
as “tested”) for CT. By assessing the role of stigma in
CT testing, disclosure of testing behaviour and encour-
agement of others to get tested, it is hoped that results
will inform new care methods that aim to increase CT




A qualitative study was conducted using semi-structured
interviews by researchers of the Public Health Service
South Limburg and Maastricht University, the Netherlands.
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Participants provided written informed consent. According
to national guidelines a Research Ethics Board reviewed
and approved this study and gave permission to interview
16 and 17 year olds without parental consent (Ethics Com-
mittee Psychology Maastricht University, reference number
13-4-054). This article adheres to the RATS guidelines on
qualitative research [33].
Recruitment of participants
Sexually active heterosexual people between 16 and
25 years were eligible for participation. Between May
and August 2013, both never CT tested (n = 13) and CT
tested (n = 10) young people were recruited for partici-
pation. Tested young people were recruited during an
STI clinic visit by nurses performing their sexual health
consultations. Never tested young people were recruited
during a sexual health education lesson at a secondary
school and via leaflets at a University, both in the same
region as the area served by the STI clinic.
Data collection
Semi-structured interviews lasting approximately 30 min,
were conducted over the telephone and tape-recorded.
Data were collected using a semi-structured interview
protocol, which was constructed in line with the opinion
of experts in the field of social psychology and stigma and
a review of the literature. All questions were related to CT
and addressed topics related to the anticipations and expe-
riences surrounding testing, disclosure, and the encour-
agement of peers to test (Table 1). Saturation occurred at
around 20 interviews, and later interviews served to con-
firm themes identified earlier in the analysis.
Analyses
The audio-recorded interviews were transcribed verba-
tim in Dutch and analysed independently by two inter-
viewers (SV and KT) using the "framework" approach
[34], which involves structured stages of data manage-
ment, descriptive accounts and explanatory accounts.
Several transcripts were explored in detail, in order for
SV and KT to become familiar with the data, after which
open coding was applied using NVivo software. Codes
were then applied to subsequent transcripts and grouped
into categories: CT testing, disclosure of CT testing, and
encouragement of peers to get tested. Furthermore, as-
sociations within categories were sought. Any disagree-
ments found in the analysis were resolved through
discussion, and consensus was reached by PS and KT
consulting a third party (i.e. ND and AB).
Results
Sample characteristics
The sample consisted of 25 interviewed participants of
whom two had to be excluded, because they were not
eligible for participation. Of the remaining participants
(n = 23), all were sexually active and heterosexual, 13
were female, 22 were of Dutch nationality, and the over-
all mean age was 20 years old (age range 16–24 years).
Of the 10 participants who had ever been tested, 7 had
tested positive for CT. Participants who had been tested
had undergone between 1 and 5 CT tests before partici-
pating in the current study.
Anticipated stigma surrounding own testing
Almost all tested and never tested participants perceived
public stigma. In several cases this was based on what
they had observed or what they heard had happened to
other young people, i.e. those who had received stigma-
tized reactions after they went for STI testing or were
found to be STI positive.
Interviewee: “Well, yes, I think that people do have
certain ideas if someone has an STI, or get certain
ideas about that person”.
Interviewer: “OK, and what kind of ideas would they
be?”
Interviewee: “That there are prejudices attached, so
that you are maybe seen as easy, or that sort of
thing… That you are more likely to have sex with
others, and that you don’t think about it so much.”
Table 1 Subject and topic list about Chlamydia testing,
disclosure of own testing behaviour and encouragement of
others to test, among tested and never tested young people
Subject Topic
General Talking about sex and sexually transmitted infections
with others
CT testing Experiences of others with testing
Opinion about others who have tested




Feelings about test results
Disclosure Experiences of others regarding the disclosure of
testing and results
Disclosure of testing to others
Disclosure of test results to others
Reasons to disclose testing to others
Reasons to disclose test results to others
Reactions of others after disclosure
Encouragement Encouragement of sex partners to test
Encouragement of friends to test
Reactions of sex partner and friends
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(Tested, female no 2, 18 years).
“That people respond to it (CT infection) differently,
react strangely, at school a girl had it and she was
always being called names … that girl was always
called a slut or things like that.”
(Never tested, female no 22, 16 years)
The perception of public stigma among never tested
participants was in line with the reported anticipated
feelings of shame when going for a CT test, but differed
from the good experiences with actual testing in tested
participants. Most never tested participants thought test-
ing would indicate unsafe sex or would be associated
with a positive test result. Others were afraid of the test-
ing procedure and the possibility of a positive test result.
Despite these factors, most never tested participants said
that they would test if they have had unsafe sex or expe-
rienced symptoms, because they valued their own health
and that of their peers. Furthermore, some also men-
tioned certainty as a reason to be tested, which was also
stated among most tested participants. Even though
tested participants were nervous in the beginning, and
did not know what to expect, both CT positives and CT
negatives stated that they were glad to know their CT
status.
Interviewee: “If I had to do a test like that then I
would probably feel a bit ashamed, because then you,
yes, you’ve maybe caught something, and then you’re
a bit ashamed”
Interviewer: “And what exactly would you be ashamed
of?”
Interviewee: “Yeah, that you just didn’t pay attention
really and that you haven’t been safe”
(Never tested, female no 9, 20 years).
“Um, if I had unsafe sex for some reason or another, I
would like to know if I’d got anything, so for yourself
it’s sensible, and also for your health, to know if you
have anything – and also for the other, should you
have had sex”
(Never tested, male no 14, 21 years).
Never tested participants reported that they expected
to feel bad if they would receive a positive test result.
However, they would also be relieved, because at that
moment they could act upon the test result and find
appropriate care. Some tested participants who were
CT positive expressed feelings of shame or anger to-
wards their sex partners. Never tested participants
would feel relieved if they received a negative test re-
sult, which was comparable with the feelings of most of
the tested participants who indeed turned out to test
CT negative. Similar responses were observed between
male and female participants regarding stigma and own
CT testing
“Well, I was really ashamed… that I had caught
something like that and hadn’t taken better care”
(Tested, female no 18, 21 years)
Disclosure of CT testing
All participants who had never tested reported that
they would disclose CT testing and test results only to
parents, good friends and sex partners whom they
trusted, and from whom they expected a positive reac-
tion (social support and empathy). Likewise, all partici-
pants who had tested stated that they had only
disclosed their test and its result to their trusted peers
(parents, friends, sex partners), receiving only positive
reactions. Tested participants reported that it was self-
evident to them that they inform sex partners. Tested
participants received positive reactions from their
trusted peers (parents, friends, sex partners). Never
tested and tested participants would not disclose to a
broader network, because they anticipated shame and
stigmatizing reactions, including gossiping and insult-
ing language. For the never tested participants shame
was associated with CT positivity and risky sexual be-
haviour. Due to the fact that no one disclosed their
testing behaviour to peers outside the trusted network,
experienced stigma from these people was avoided and
tested participants reported no negative reactions.
Similar responses were observed between men and
women regarding their disclosure of test behaviour and
results.
Interviewer: “And do you expect a reaction from them
(good friends) when you tell them (about the test and
results)?”
Interviewee: “Yes you could call it empathy what you
expect, but also that they can help you or that they
have gone through something similar that makes it
easier for you to cope, as it were.”
(Never tested, male no 17, 23 years)
“Yeah, I’m not someone who would just throw that
out there. That’s what I have my most trusted friend
for, one or two. And with them I talk about it and
then I ask advice and then for me it’s fine, actually.”
(Tested, male no 23, 20 years).
“It is something about myself, not everyone needs to
know that I have it… Yeah, I won’t be called a little
slut, or have people think that I jump into bed with
everyone or something.”
(Tested, female no 21, 22 years)
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Encouraging others to get tested
Most of the never tested participants indicated that, if
they happened to be CT positive, they would encourage
sex partners to test, because they want to prevent trans-
mission or would be concerned about their own and
their partner’s health. Likewise, all tested participants
had already, or would in the future personally encourage
sex partners to test although they would find it difficult
to do so. Some tested participants had themselves been
encouraged by their sex partner or by someone within
their trusted network to test for CT. A few tested partic-
ipants and peers visited the clinic together for testing.
Interviewer: “And why do you find it important that
she is also tested?”
Interviewee: “Yeah, if I have it then she can also have
it and imagine that she has it and then we do it again,
and I’ll have it again.”
(Never tested, male no 5, 17 years)
“The last time that I had myself tested was because I
heard via a former sex partner that he had got
Chlamydia and that I should also be tested.”
(Tested, female no 1, 21 years)
Despite anticipated negative reactions such as anger or
shock, never tested participants thought that their sex
partners would go for a CT test once they had been en-
couraged by the participant to do so. This is in line with
the positive experiences among tested participants where
several sex partners they had talked to also got CT
tested. Tested participants had not experienced negative
reactions when encouraging others to test.
“I think that they (sex partners) would also be a bit
angry, yeah, I would be too, like yeah, how can it have
happened? But on the other hand I also really think
that it’s good that I tell him so that he can get himself
tested.”
(Never tested, female no 9, 20 years)
Most of the never tested and tested participants antici-
pated that they would also encourage a trusted network
of good friends to test; friends with whom they already
talk about sex or STIs or who they know have had un-
safe sex or multiple sex partners. Some never tested par-
ticipants anticipated negative reactions like laughing or
anger if they would encourage a friend to get tested. Sev-
eral never tested participants expressed the opinion that
it was the responsibility of these friends to test for CT
when necessary. Most tested participants did not antici-
pate negative reactions from friends and some had
already encouraged friends to test. Similar responses
were observed between men and women regarding the
encouragement of others to test for CT.
“Yeah, you could of course start talking about it, but if
you haven’t, for example, ever talked about sex or
something like that with a person, that person’s not a
good friend, but a stranger or someone, then you’re
not going to suddenly say you should have a
Chlamydia test done, anyway, that’s not something I
would do.”
(Never tested, male no 11, 17 years)
“Yes, I expect that they would maybe also be slightly
angry that I have the idea that they maybe have
Chlamydia, but I think that they would probably take
that on board and let themselves be tested after all,
just to be sure.”
(Never tested, female no 22, 16 years)
“I know in this case that my female friends… that it is
the case that if someone said to me, well yes, I went
to Spain last month on holiday and I had unsafe sex
there, that I could just say, well yeah, I would go to
the GGD [STI clinic], if I were you. In that sense our
group is very straightforward about things like that
and we are not ashamed about it.”
(Tested, female no 25, 24 years)
Discussion
The present study explored the role of stigma in relation
to CT testing, the disclosure of testing to peers, and the
encouragement of peers to get tested, in a group of young
never tested and tested heterosexual individuals.
Perceived public stigma and anticipated self-stigma were
reported regardless of whether people had ever tested for
CT or not. Nevertheless, all participants either intended to
test when needed or had indeed tested already. This find-
ing is in line with some other studies among tested and
never tested young people in clinics, community based
organizations, and household samples, where shame
was not found to be a barrier to STI testing [12, 35]. A
study among young women in general practitioners set-
tings and family planning clinics demonstrated that fear of
stigmatization if they accepted screening did not lead to
rejection of CT testing when it was offered to them [36].
Tested and never tested participants disclosed both
their test behaviour and, when tested, their test result to
a small, trusted network of peers. They anticipated posi-
tive reactions such as support and empathy from this
small network. Similar results have been found in a
study among young Irish adults who informed a few
“key individuals” after their testing experience, because
they helped them to feel normal and gave them emo-
tional support [25]. Among the tested participants in
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this study, it was self-evident that they disclosed their
CT testing and results to their sex partners, which is in
line with previous studies about PN and STIs [13]. Despite
the potential self-stigma and public stigma associated with
notifying sex partners, many young people consider part-
ner notification in practice “the right thing to do”, and
people’s experiences with PN were much better than they
had initially expected [13, 27, 37]. Stigmatizing reactions
and shame were anticipated among all participants when
disclosing details of their CT testing and results to a “non-
trusted” broader network of peers. However, it has been
shown that people try to minimize or regulate the negative
psychological and social impact of stigma by using
problem-focused and emotion-focused coping strategies
[38, 39]. In the present study, participants used selective
disclosure as such stigma management strategy, and in-
deed no tested participants in this study had experienced
stigmatizing reactions. Fear of stigmatization and the se-
lective disclosure to a few key individuals has also been
found in other studies regarding the disclosure of STI test-
ing and test results [25, 26], and moreover in studies in-
vestigating stigma associated with mental illnesses [40].
Disclosure does not automatically lead to the encour-
agement of peers to test for CT. Novel approaches that
deploy social and sexual networks in order to get high-
risk individuals tested for CT place importance on pro-
active encouragement among young people [17]. Never
tested participants reported that they would encourage
sex partners to get tested if they themselves tested CT
positive. This finding is in line with the experience of
tested participants who were either encouraged by peers
or who themselves had encouraged friends or sex part-
ners to get tested. Again, stigma management strategies
resulted in the encouragement only of a select trusted
circle of sex partners and friends to test for CT.
In contrast to findings in other studies [32, 41], in our
study, men did not report less CT-related stigma or
shame compared to women. No differences were ob-
served between men and women regarding their stigma
management strategies.
Recommendations
People do test for CT, including those who anticipate
stigma. Despite anticipated stigma social and sexual net-
works can be reached for testing. Therefore, care strat-
egies that deploy sexual and social networks to reach
high-risk young people with CT testing are potentially
effective. Yet, their effectiveness will potentially be lim-
ited by the small size of trusted networks reached due to
people’s stigma management strategies. With selective
disclosure and encouragement (to get tested) young
people protect themselves from anticipated stigma from
peers outside their trusted peer networks. Nonetheless, a
person outside an individual’s trusted network may still
be reached by such care strategies, because he or she
may be a trusted peer in someone else’s network. Care
methods, such as web-based applications that already
reach high risk trusted networks, will benefit from includ-
ing ways to overcome anticipated stigma without increas-
ing the impact of experienced stigma from outside these
trusted networks. For example, via anonymous disclosure
and encouragement, or by the use of home-based sam-
pling kits, which have been shown to greatly facilitate the
management of sexual partners [15, 42]. Sexual health care
providers such as nurses and physicians have also an im-
portant role to play in the motivation and guidance of
young people disclosing to their peers and encouraging
them to get tested [43]. Care providers are generally
trained in Motivational Interviewing (MI). MI targets the
intrinsic motivation of people to change behaviour by sup-
porting people to examine and resolve ambivalence to
their needs and abilities [44]. MI is already used in PN, yet
its use can be explored to reach trusted social networks
but even more, to reach non-trusted networks.
Strengths and weaknesses of the present study
One of the strengths of this study is the inclusion of en-
couragement of peers. Several studies assessing stigma
have been conducted regarding the disclosure of CT
testing to sex partners and friends, but to our knowledge
none of these have included encouragement of peers. A
further strength of this study is the comparison between
the hypothetical behaviour and anticipations among
never tested young people with the real behaviour and
experiences of tested young people. One possible limita-
tion of our study is that all our tested participants were
from Dutch STI clinics and all our never tested partici-
pants were from the general community (i.e., secondary
school and university), and these groups might differ re-
garding STI knowledge and/or sexual risk behaviour.
Nevertheless, we found that perceived public stigma and
behavioural intentions regarding testing, disclosing and
encouragement were largely similar between our tested
and never tested participants. By including tested and
untested young people from different backgrounds and
gender, we do consider it likely that the results of this
study provide a general theoretical understanding of
how stigma plays a role in testing and disclosure that
may be exported to provide explanatory theory for the
experiences of other individuals who are in comparable
situations. It is unknown whether results can be extrapo-
lated to other target groups (i.e. men having sex with
men or commercial sex workers) and to other STIs (i.e.
syphilis and HIV), because of differences in sexual risk
behaviour and severity of the illness, and possible related
differences in anticipated stigma. Therefore, caution is
warranted with regard to the generalization of these
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findings to other target groups than young heterosexuals
and other STI than CT.
Conclusion
Young people perceive public stigma, they anticipate
self-stigma and feelings of shame when they test for CT,
disclose their test behaviour to peers, and encourage
their peers to get tested. Nevertheless, despite these po-
tential barriers, young people have been tested, or have
expressed the intention to test for, CT. As a protection
against anticipated stigmatizing reactions, people use
stigma management strategies such as selective disclos-
ure and the encouragement of only a small trusted peer
network to test for CT. Care strategies that deploy the
sexual and social networks of individuals can reach into
small networks surrounding a person. These strategies
could be improved by exploring methods to reach high-
risk network members outside the small trusted circle of
a young person.
Key messages
 Young people perceive public stigma with
Chlamydia testing
 Despite feelings of shame and anticipated self-
stigma, young people would be willing to test for
Chlamydia
 Stigma surrounding disclosure of testing behaviour
and encouragement of others to test is anticipated.
However the experience of stigma is effectively
avoided by only disclosing to a small trusted peer
group.
 Young people use stigma management strategies
such as selective disclosure and selective
encouragement of trusted others to protect
themselves from stigmatizing reactions
 Care strategies that deploy social and sexual
networks to invite young people to test for
Chlamydia need to take into account the small size
of these trusted peer networks.
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